David E. Morse
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Nicotinic Acetylcholine Receptors Study 3
-
- Renal cell carcinoma treatment 2
- Co-authors
- Richard Pazdur (10 shared papers)Neil E. Grunberg (5 shared papers)Robert Justice (6 shared papers)Rajeshwari Sridhara (6 shared papers)Brian Booth (6 shared papers)Sophia Abraham (4 shared papers)Deborah J. Bowen (1 shared paper)Ramzi Dagher (4 shared papers)
- Journals
- Clinical Cancer Research (7 papers)Psychopharmacology (4 papers)Journal of Clinical Oncology (1 paper)Journal of Applied Social Psychology (1 paper)The Oncologist (1 paper)
- Partner nations
- United States
In The Last Decade
David E. Morse
18 papers receiving 2.5k citations
David E. Morse's Hit Papers
Peers
Comparison fields: 5 of 112
- Hematology 266
- Oncology 600
- Pulmonary and Respiratory Medicine 586
- Gastroenterology 95
- Genetics 173
Countries citing papers authored by David E. Morse
This map shows the geographic impact of David E. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Morse more than expected).
Fields of papers citing papers by David E. Morse
This network shows the impact of papers produced by David E. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Morse. The network helps show where David E. Morse may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Morse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 418 | |
| 2 | Approval Summary: Sunitinib for the Treatment of Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors and Advanced Renal Cell Carcinoma Hit paper breakdown → | 2007 | 407 |
| 3 | 2006 | 398 | |
| 4 | 2007 | 222 | |
| 5 | 2007 | 210 | |
| 6 | 1984 | 196 | |
| 7 | 2008 | 190 | |
| 8 | 1994 | 101 | |
| 9 | 2005 | 93 | |
| 10 | 2006 | 67 | |
| 11 | 1991 | 56 | |
| 12 | 1996 | 56 | |
| 13 | Fulvestrant in postmenopausal women with advanced breast cancer. | 2003 | 46 |
| 14 | 1989 | 40 | |
| 15 | 1984 | 28 | |
| 16 | 1987 | 20 | |
| 17 | 1983 | 7 | |
| 18 | 2005 | 4 | |
| 19 | 1969 | 1 |
About David E. Morse
David E. Morse is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nicotinic Acetylcholine Receptors Study (3 papers), Renal cell carcinoma treatment (2 papers), Smoking Behavior and Cessation (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Obesity, Physical Activity, Diet (1 paper), Cancer Genomics and Diagnostics (1 paper) and Bone and Dental Protein Studies (1 paper). The work is most often cited by research in Hematology (266 citations), Oncology (600 citations), Pulmonary and Respiratory Medicine (586 citations), Gastroenterology (95 citations) and Genetics (173 citations). David E. Morse has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Neil E. Grunberg, Robert Justice, Rajeshwari Sridhara, Brian Booth, Sophia Abraham, Deborah J. Bowen, Ramzi Dagher, Nallaperumal Chidambaram and Vicki Goodman. Their work appears in journals such as Clinical Cancer Research, Psychopharmacology, Journal of Clinical Oncology, Journal of Applied Social Psychology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.